Express Scripts Holding (ESRX) Receives Consensus Rating of “Hold” from Brokerages

Shares of Express Scripts Holding (NASDAQ:ESRX) have been assigned an average rating of “Hold” from the twenty-six brokerages that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $79.66.

A number of research firms have recently issued reports on ESRX. BidaskClub lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank of Canada raised shares of Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 price target for the company in a research report on Wednesday, January 31st. Sanford C. Bernstein lowered shares of Express Scripts from a “market perform” rating to an “underperform” rating and increased their price target for the stock from $55.80 to $77.50 in a research report on Tuesday, January 30th. Mizuho set a $86.00 price target on shares of Express Scripts and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, SunTrust Banks reissued a “buy” rating and issued a $95.00 price target on shares of Express Scripts in a research report on Friday, January 12th.

In other Express Scripts news, VP Glen D. Stettin sold 3,449 shares of the stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the transaction, the vice president now owns 33,715 shares in the company, valued at $2,730,915. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Glen D. Stettin sold 3,448 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The disclosure for this sale can be found here. Insiders sold 17,001 shares of company stock worth $1,249,505 in the last 90 days. 0.68% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in ESRX. Janus Henderson Group PLC grew its holdings in Express Scripts by 39.1% during the second quarter. Janus Henderson Group PLC now owns 111,811 shares of the company’s stock valued at $7,138,000 after purchasing an additional 31,420 shares during the last quarter. Sciencast Management LP acquired a new position in Express Scripts during the second quarter valued at approximately $566,000. Cubist Systematic Strategies LLC acquired a new position in Express Scripts during the second quarter valued at approximately $3,422,000. Gyroscope Capital Management Group LLC bought a new stake in shares of Express Scripts in the second quarter valued at approximately $290,000. Finally, Arrowstreet Capital Limited Partnership boosted its position in shares of Express Scripts by 40.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,879,400 shares of the company’s stock valued at $119,981,000 after acquiring an additional 541,300 shares during the period. Institutional investors own 87.46% of the company’s stock.

Express Scripts (NASDAQ:ESRX) traded up $0.70 during midday trading on Wednesday, hitting $73.59. 3,720,900 shares of the stock were exchanged, compared to its average volume of 4,276,801. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $41,282.93, a price-to-earnings ratio of 12.12, a price-to-earnings-growth ratio of 0.78 and a beta of 0.93. Express Scripts has a 1-year low of $55.80 and a 1-year high of $83.49.

Express Scripts declared that its board has approved a share repurchase program on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: This article was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2018/02/14/express-scripts-holding-esrx-receives-consensus-rating-of-hold-from-brokerages.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply